Page last updated: 2024-11-05

tranexamic acid and Coronary Disease

tranexamic acid has been researched along with Coronary Disease in 5 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, SW1
Shim, JK1
Youn, YN1
Song, JW1
Yang, SY1
Chung, SC1
Kwak, YL1
Lucas-Polomeni, MM1
Delaval, Y1
Menestret, P1
Delaval, P1
Ecoffey, C1
Blauhut, B1
Harringer, W1
Bettelheim, P1
Doran, JE1
Späth, P1
Lundsgaard-Hansen, P1
de Bono, DP1
More, RS1
Casati, V1
Gerli, C1
Franco, A1
Torri, G1
D'Angelo, A1
Benussi, S1
Alfieri, O1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effect of Tranexamic Acid on Blood Loss and Transfusion Rates in Major Oncologic Surgery[NCT01980355]76 participants (Actual)Interventional2012-06-12Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Estimated Blood Loss

Surgical blood loss estimation (NCT01980355)
Timeframe: From time of surgery to 90 days post hospital discharge

InterventionmL (Median)
Tranexamic Acid450
Placebo365

Number of Participants Who Required Transfusion

To determine the impact of perioperative administration of tranexamic acid on blood loss and transfusion rates in major oncologic surgery (NCT01980355)
Timeframe: From time of surgery to 90 days post hospital discharge

InterventionParticipants (Count of Participants)
Tranexamic Acid8
Placebo5

Reviews

1 review available for tranexamic acid and Coronary Disease

ArticleYear
Prevention and management of bleeding complications after thrombolysis.
    International journal of cardiology, 1993, Volume: 38, Issue:1

    Topics: Aprotinin; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Drug Interactions; Fibr

1993

Trials

3 trials available for tranexamic acid and Coronary Disease

ArticleYear
Effect of tranexamic acid on transfusion requirement in dual antiplatelet-treated anemic patients undergoing off-pump coronary artery bypass graft surgery.
    Circulation journal : official journal of the Japanese Circulation Society, 2012, Volume: 76, Issue:1

    Topics: Aged; Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Comorbidity; Coronar

2012
Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass.
    The Journal of thoracic and cardiovascular surgery, 1994, Volume: 108, Issue:6

    Topics: Aged; Analysis of Variance; Aprotinin; Blood Coagulation Tests; Blood Loss, Surgical; Cardiopulmonar

1994
Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study.
    The Annals of thoracic surgery, 2001, Volume: 72, Issue:2

    Topics: Aged; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Disease; Double-Blind Method; Drug Ad

2001

Other Studies

1 other study available for tranexamic acid and Coronary Disease

ArticleYear
[A case of anaphylactic shock with tranexamique acid (Exacyl)].
    Annales francaises d'anesthesie et de reanimation, 2004, Volume: 23, Issue:6

    Topics: Aged; Anaphylaxis; Antifibrinolytic Agents; Coronary Artery Bypass; Coronary Disease; Drug Hypersens

2004